Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 33 (BNIP3P33)

Target
BNIP3P33
Molecular classification
Other (Pseudogene, not protein coding)
01

Overview

BNIP3P33, or BCL2 interacting protein 3 pseudogene 33, is a pseudogene related to the BNIP3 gene. A pseudogene is a genomic DNA sequence similar to a gene but generally non-functional; it usually does not encode a functional protein, and there is no evidence that BNIP3P33 itself acts as a therapeutic target, encodes an active receptor, or participates in cell signaling or disease processes. Pseudogenes may, in some cases, transcribe non-coding RNAs, which can have regulatory functions or act as competing endogenous RNAs, but there is no specific evidence for BNIP3P33's biological role. Entries describing it (such as in NCBI and Ensembl) indicate it is classified as a pseudogene with no associated protein function or drug targeting information. BNIP3P33 is not a receptor, enzyme, transporter, or therapeutic target, and there are no drugs, mechanisms of action, or disease roles attributed to it. It is best classified as a non-coding, non-target molecule. There is nothing inherently misspelled in the name, but biologically, it is "incorrect" for most drug discovery/target validation purposes.

Other names
BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 33BNIP3P33

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 33 (BNIP3P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 33 (BNIP3P33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call